Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

DexCom Rises After Q3 Results Top Expectations and 2026 Outlook Improves

None

DexCom (DXCM) is up 4.8% today. Here is some analysis on what might have caused this price movement. ([investors.dexcom.com](https://investors.dexcom.com/news/news-details/2026/Dexcom-Reports-Third-Quarter-2026-Financial-Results/default.aspx?utm_source=openai))

Analysis: The move appears tied mainly to DexCom’s third-quarter results, which showed double-digit revenue growth, better profitability, and a higher full-year revenue midpoint alongside improved operating margin guidance. Investors also seemed to welcome a new $1.0 billion share repurchase authorization and a favorable analyst target increase after the report. ([investors.dexcom.com](https://investors.dexcom.com/news/news-details/2026/Dexcom-Reports-Third-Quarter-2026-Financial-Results/default.aspx?utm_source=openai))

Details:

  • Third-quarter 2026 revenue rose 11% year over year to $1.344 billion, with U.S. revenue up 14%, while non-GAAP operating margin improved to 25.3%. ([investors.dexcom.com](https://investors.dexcom.com/news/news-details/2026/Dexcom-Reports-Third-Quarter-2026-Financial-Results/default.aspx?utm_source=openai))
  • DexCom raised the midpoint of its 2026 revenue outlook to a range of $5.20 billion to $5.25 billion and also increased its operating margin and adjusted EBITDA margin guidance. ([investors.dexcom.com](https://investors.dexcom.com/news/news-details/2026/Dexcom-Reports-Third-Quarter-2026-Financial-Results/default.aspx?utm_source=openai))
  • The company announced a fresh $1.0 billion buyback authorization in conjunction with the quarterly release, adding another shareholder-friendly element to the update. ([investors.dexcom.com](https://investors.dexcom.com/news/news-details/2026/Dexcom-Reports-Third-Quarter-2026-Financial-Results/default.aspx?utm_source=openai))
  • A Wall Street target increase highlighted faster U.S. sales growth plus stronger-than-expected margins and cash flow, which likely added support to the post-earnings reaction. ([investing.com](https://www.investing.com/news/analyst-ratings/raymond-james-raises-dexcom-stock-price-target-to-97-on-us-growth-93CH-4986235?utm_source=openai))
  • Sources:

    DexCom Investor Relations, SEC, Investing.com ([investors.dexcom.com](https://investors.dexcom.com/news/news-details/2026/Dexcom-Reports-Third-Quarter-2026-Financial-Results/default.aspx?utm_source=openai))

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $DXCM Insider Trading Activity

    DXCM Insider Trades

    $DXCM insiders have traded $DXCM stock on the open market 26 times in the past 6 months. Of those trades, 0 have been purchases and 26 have been sales.

    Here’s a breakdown of recent trading of $DXCM stock by insiders over the last 6 months:

    • KEVIN R SAYER (Executive Chair) has made 0 purchases and 6 sales selling 107,027 shares for an estimated $8,303,321.
    • MICHAEL JON BROWN (EVP Chief Legal Compliance Off) has made 0 purchases and 6 sales selling 10,200 shares for an estimated $801,261.
    • JON COLEMAN (EVP, Chief Commercial Officer) has made 0 purchases and 2 sales selling 9,823 shares for an estimated $722,628.
    • NICHOLAS AUGUSTINOS has made 0 purchases and 2 sales selling 8,089 shares for an estimated $679,768.
    • SADIE STERN (EVP Chief People & Culture Off) has made 0 purchases and 3 sales selling 7,695 shares for an estimated $649,304.
    • MARK G FOLETTA has made 0 purchases and 4 sales selling 8,000 shares for an estimated $627,179.
    • JEREME M SYLVAIN (EVP, Chief Financal Officer) sold 3,638 shares for an estimated $302,936
    • BRIDGETTE P HELLER has made 0 purchases and 2 sales selling 2,024 shares for an estimated $150,079.

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

    EARLY ACCESS
    Receive DXCM Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $DXCM Hedge Fund Activity

    We have seen 533 institutional investors add shares of $DXCM stock to their portfolio, and 452 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

    $DXCM Congressional Stock Trading

    Members of Congress have traded $DXCM stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

    Here’s a breakdown of recent trading of $DXCM stock by members of Congress over the last 6 months:

    To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

    $DXCM Price Targets

    Multiple analysts have issued price targets for $DXCM recently. We have seen 9 analysts offer price targets for $DXCM in the last 6 months, with a median target of $85.0.

    Here are some recent targets:

    • Kieran Ryan from Deutsche Bank set a target price of $86.0 on 06/23/2026
    • Matt O'Brien from Piper Sandler set a target price of $88.0 on 06/15/2026
    • Joshua Jennings from TD Cowen set a target price of $95.0 on 06/10/2026
    • Anthony Petrone from Mizuho set a target price of $85.0 on 06/09/2026
    • Jonathan Block from Stifel set a target price of $90.0 on 06/05/2026
    • Joanne Wuensch from Citigroup set a target price of $84.0 on 05/28/2026
    • Matt Miksic from Barclays set a target price of $64.0 on 05/18/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles